St. Louis, MO (July 19, 2016) – Remarkable strides in precision medicine applications are addressing the ever-growing human need for new breakthroughs in precision diagnostics and treatments for mankind’s most challenging diseases. A new conference will highlight progress at the confluence of genomics, medicine, and health: AGBT-Precision Health.
The AGBT-Precision Health conference builds upon the successful model defined by the annual Advances in Genome Biology and Technology (AGBT) meeting, recognized worldwide as the leading genomic technology research conference. Held in Scottsdale, Arizona, from September 22 to 24, AGBT-Precision Health unites the world’s leading clinical translation professionals for three days of keynote talks and industry insights.
“In organizing AGBT-Precision Health, we sought to emphasize the current trends in clinical translation of next-generation sequencing, permitting attendees to get a sense of the cutting-edge applications and analytical combinations that are changing the clinical reality for patients across the spectrum of diagnosis and disease treatment,” commented Elaine Mardis, PhD, who co-chairs the organizing committee for AGBT-Precision Health.
The agenda features presentations by many practitioners and technologists in precision health, including:
Diana Bianchi, Tufts Medical Center
Stephen Kingsmore, Rady Children’s Hospital
Heidi Rehm, Harvard Medical School
Richard Daly, DNAnexus
William Gahl, National Human Genome Research Institute, National Institutes of Health
Mia Levy, Vanderbilt-Ingram Cancer Center
Amy McGuire, Baylor College of Medicine
Nickolas Papadopoulos, Johns Hopkins School of Medicine
Kenna Mills Shaw, MD Anderson Cancer Center
Alan Shuldiner, Regeneron Genetics Center
Howard Jacob, HudsonAlpha
Imran Haque, Counsyl
“There is a large gap between advances occurring in genomic research and implementation at the bedside,” said Diana Bianchi, M.D., a member of the scientific organizing committee and co-chair of our pre-conference workshop. “It is incumbent upon us to educate practitioners and patients with regard to the clinical relevance of genomics. That’s why I am looking forward to the larger discussions at the new ABGT-Precision Health conference and to our pre-conference workshop, designed to offer clinicians and trainees a stronger background in genomics as it is being applied to precision health.”
Pre-Conference Topics include:
NGS 101
NGS data analysis
Challenges of NGS data interpretations
NGS applications lectures and roundtables
Other Conference Highlights:
The Great Debate-Panels vs. Exomes vs. Genomes
Mock Tumor Board
The AGBT-Precision Health conference builds upon the successful model defined by the annual Advances in Genome Biology and Technology (AGBT) meeting, recognized worldwide as the leading genomic technology research conference. Held in Scottsdale, Arizona, from September 22 to 24, AGBT-Precision Health unites the world’s leading clinical translation professionals for three days of keynote talks and industry insights.
“In organizing AGBT-Precision Health, we sought to emphasize the current trends in clinical translation of next-generation sequencing, permitting attendees to get a sense of the cutting-edge applications and analytical combinations that are changing the clinical reality for patients across the spectrum of diagnosis and disease treatment,” commented Elaine Mardis, PhD, who co-chairs the organizing committee for AGBT-Precision Health.
The agenda features presentations by many practitioners and technologists in precision health, including:
Diana Bianchi, Tufts Medical Center
Stephen Kingsmore, Rady Children’s Hospital
Heidi Rehm, Harvard Medical School
Richard Daly, DNAnexus
William Gahl, National Human Genome Research Institute, National Institutes of Health
Mia Levy, Vanderbilt-Ingram Cancer Center
Amy McGuire, Baylor College of Medicine
Nickolas Papadopoulos, Johns Hopkins School of Medicine
Kenna Mills Shaw, MD Anderson Cancer Center
Alan Shuldiner, Regeneron Genetics Center
Howard Jacob, HudsonAlpha
Imran Haque, Counsyl
“There is a large gap between advances occurring in genomic research and implementation at the bedside,” said Diana Bianchi, M.D., a member of the scientific organizing committee and co-chair of our pre-conference workshop. “It is incumbent upon us to educate practitioners and patients with regard to the clinical relevance of genomics. That’s why I am looking forward to the larger discussions at the new ABGT-Precision Health conference and to our pre-conference workshop, designed to offer clinicians and trainees a stronger background in genomics as it is being applied to precision health.”
Pre-Conference Topics include:
NGS 101
NGS data analysis
Challenges of NGS data interpretations
NGS applications lectures and roundtables
Other Conference Highlights:
The Great Debate-Panels vs. Exomes vs. Genomes
Mock Tumor Board
